Cargando…
Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment
Glioblastoma is the most common and lethal brain tumor in adults. The incorporation of temozolomide (TMZ) into the standard treatment has increased the overall survival rate of glioblastoma patients. Since then, significant advances have been made in understanding the benefits and limitations of TMZ...
Autores principales: | Iturrioz-Rodríguez, Nerea, Sampron, Nicolas, Matheu, Ander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240814/ https://www.ncbi.nlm.nih.gov/pubmed/37284445 http://dx.doi.org/10.7150/thno.82005 |
Ejemplares similares
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
por: Egaña, Larraitz, et al.
Publicado: (2020) -
Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019) -
Lipid-Based Nanocarriers for The Treatment of Glioblastoma
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2020) -
Primary cilium and glioblastoma
por: Álvarez-Satta, María, et al.
Publicado: (2018) -
Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2020)